Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 923 $ 876
Restricted cash 1,000 860
Accounts and other receivables 290 218
Inventory 113 160
Derivative assets 19 24
Other current assets 74 100
Total current assets 2,419 2,238
Non-current restricted cash 1,018 91
Property, plant and equipment, net 22,016 20,635
Debt issuance costs, net 244 277
Non-current derivative assets 44 83
Goodwill 77 77
Other non-current assets, net 238 302
Total assets 26,056 23,703
Current liabilities    
Accounts payable 54 49
Accrued liabilities 683 637
Current debt, net 24 247
Deferred revenue 63 73
Derivative liabilities 47 71
Total current liabilities 871 1,077
Long-term debt, net 24,088 21,688
Non-current deferred revenue 5 5
Non-current derivative liabilities 38 45
Other non-current liabilities 59 49
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at March 31, 2017 and December 31, 2016; Issued: 250.1 million shares and 250.1 million shares at March 31, 2017 and December 31, 2016, respectively
Outstanding: 237.9 million shares and 238.0 million shares at March 31, 2017 and December 31, 2016, respectively 1 1
Treasury stock: 12.2 million shares at March 31, 2017 and December 31, 2016, at cost (375) (374)
Additional paid-in-capital 3,218 3,211
Accumulated deficit (4,180) (4,234)
Total stockholders’ deficit (1,336) (1,396)
Non-controlling interest 2,331 2,235
Total equity 995 839
Total liabilities and equity $ 26,056 $ 23,703